The presence of trisomy 12 and a mutated IGHV region were considered favorable prognostic markers in some studies (19, 20); thus, we propose that the use of IGHJ3 genes possibly correlates with better outcomes in CLL. The gene discussed is IGHJ3; the disease is B-cell chronic lymphocytic leukemia.